23andMe Holding Co.

23andMe Holding Co.

World Rank (Jan-05-2024)
13,988
Market Cap (Jan-05-2024)
0.399 Billion USD
World Rank (Jul-30-2023)
9,578
Market Cap (Jul-30-2023)
0.849 Billion USD
World Rank (Jan-07-2022)
5,045
Market Cap (Jan-07-2022)
2.842 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
ME
Employee Count
746
Employee Count as of Date
As on April 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
271 Million USD
Annual Net Income in USD
-217 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Total Assets in USD
1,152 Million USD
Total Liabilities in USD
236 Million USD
Total Equity in USD
915 Million USD
Balance Sheet for Period Ending
Mar-2022 ending year
Business Sector
Healthcare
Health Care Diagnostics
Biotechnology
Company Website
23ANDME HOLDING CO.
Company Profile
23andMe is the technology to genotype and Biotechnology company. The headquarters is in USA.
Facts About Company
23andMe company annual revenue was 299 million USD and annual net loss was -311 as on Mar-2023.
Founded Year
2006
Nasdaq Sector
Health Care
Nasdaq Industry
Precision Instruments

Share